Key terms
About COCP
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded in 2008 and is headquartered in Bothell, WA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest COCP news
Apr 04
6:31am ET
Analysts Offer Insights on Healthcare Companies: Cocrystal Pharma (COCP) and Icecure Medical (ICCM)
Mar 28
8:03am ET
Cocrystal Pharma sees cash runway beyond next 12 months
Mar 28
8:02am ET
Cocrystal Pharma reports 2023 EPS ($1.87), consensus ($2.09)
Mar 20
6:26am ET
Cocrystal Pharma’s Promising Influenza A Treatment Garners Buy Rating from Analyst Ram Selvaraju
Mar 19
8:42am ET
Cocrystal Pharma Advances Influenza A Treatment Development
Mar 19
8:05am ET
Cocrystal Pharma receives pre-IND responses from FDA on oral CC-42344
COCP Financials
Key terms
Ad Feedback
COCP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
COCP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
